Literature DB >> 1731923

Structure of epidermal growth factor bound to perdeuterated dodecylphosphocholine micelles determined by two-dimensional NMR and simulated annealing calculations.

D Kohda1, F Inagaki.   

Abstract

The interaction of mouse epidermal growth factor (mEGF) with micelles of a phospholipid analogue, perdeuterated dodecylphosphocholine (DPC), was investigated by two-dimensional 1H NMR. Sequence-specific resonance assignments of the micelle-bound mEGF have been made, and the chemical shifts were compared with those in the absence of DPC. DPC induced large chemical shift changes of the resonances from the residues in the C-terminal tail (residues 46-53) but little perturbation on the residues in the main core (residues 1-45). Starting from the three-dimensional structure in the absence of DPC, micelle-bound structures were calculated using the program XPLOR with interproton distance data obtained from NOESY spectra recorded in the presence of DPC. The C-terminal tail of mEGF was found to change conformation to form an amphiphilic structure when bound to the micelles. It is possible that induced fit in the C-terminal tail of mEGF occurs upon binding to a putative hydrophobic pocket of the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731923     DOI: 10.1021/bi00118a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Membrane catalysis of peptide-receptor binding.

Authors:  David N Langelaan; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

2.  The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Authors:  L N Klapper; S Glathe; N Vaisman; N E Hynes; G C Andrews; M Sela; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Simulated annealing with restrained molecular dynamics using CONGEN: energy refinement of the NMR solution structures of epidermal and type-alpha transforming growth factors.

Authors:  R Tejero; D Bassolino-Klimas; R E Bruccoleri; G T Montelione
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

4.  Combined use of 13C chemical shift and 1H alpha-13C alpha heteronuclear NOE data in monitoring a protein NMR structure refinement.

Authors:  B Celda; C Biamonti; M J Arnau; R Tejero; G T Montelione
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

5.  NMR analyses of the interaction between the FYVE domain of early endosome antigen 1 (EEA1) and phosphoinositide embedded in a lipid bilayer.

Authors:  Mariko Yokogawa; Yoshihiro Kobashigawa; Naoki Yoshida; Kenji Ogura; Kohsuke Harada; Fuyuhiko Inagaki
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

6.  Three intrinsically unstructured mussel adhesive proteins, mfp-1, mfp-2, and mfp-3: analysis by circular dichroism.

Authors:  Dong Soo Hwang; J Herbert Waite
Journal:  Protein Sci       Date:  2012-09-25       Impact factor: 6.725

7.  High resolution 1H nuclear magnetic resonance of a transmembrane peptide.

Authors:  J H Davis; M Auger; R S Hodges
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

8.  Interaction of recombinant human epidermal growth factor with phospholipid vesicles. A steady-state and time-resolved fluorescence study of the bis-tryptophan sequence (Trp49-Trp50).

Authors:  I M Li De La Sierra; M Vincent; G Padron; J Gallay
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

9.  Lipid interaction networks of peripheral membrane proteins revealed by data-driven micelle docking.

Authors:  Felician Dancea; Keiichiro Kami; Michael Overduin
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

10.  Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Authors:  K Nagata; D Kohda; H Hatanaka; S Ichikawa; S Matsuda; T Yamamoto; A Suzuki; F Inagaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.